Home › Trial NCT07676331
Clinical Study of Local and Systemic Biological Impact of GLP1/GIP-Receptor Agonists in Patients With Breast Cancer: The CLARA Trial
- Trial IDNCT07676331
- StatusNot Yet Recruiting
- PhasePhase 2
- Study typeInterventional
- SponsorUniversitaire Ziekenhuizen KU Leuven
- Enrollment168
- Start date2026-08-01
- ConditionsHormone-receptor-positive Breast Cancer · Early Breast Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.